It can be dosed once a week due to its ability to bind to albumin using acylation technology
Their effect has been dramatic with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average
37% of people taking 120mg of orlistat 3 times per day lose 5% or more of their starting weight after 12 weeks
We currently offer a range of ready-to-use products targeting GCGR, including recombinant ECD proteins, synthetic nanodisc full-length multi-transmembrane proteins, biosimilar reference antibodies, and biotin-labeled antibodies
Patients with reduced kidney function may require modified dosages or alternative approaches to ensure safe treatment
Eardley, I., Ellis, P., Boolell, M., & Wulff, M